Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2017.4625
Abstract: Importance Physicians need information on how to use the first available high-sensitivity troponin (hsTnT) assay in the United States to identify patients at very low risk for 30-day adverse cardiac events (ACE). Objective To determine… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.22597
Abstract: Key Points Question Is dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor associated with better clinical outcomes for patients with acute coronary syndrome treated with coronary artery bypass grafting compared with ASA monotherapy? Findings… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.55709
Abstract: Key Points Question Is short-term oral rivaroxaban a noninferior alternative to parenteral enoxaparin in the acute phase of acute coronary syndrome (ACS)? Findings This equivalence and noninferiority trial including 2046 patients found that short-term rivaroxaban… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Annals of Neurology"
DOI: 10.1002/ana.26646
Abstract: A 54-year-old woman, active smoker, presented to the emergency department (ED) because of chest pain and shortness of breath. Both the blood test for myocardial enzymes and the electrocardiogram supported the diagnosis of acute coronary… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27551
Abstract: To evaluate the impacts of stent techniques on long‐term clinical outcomes after percutaneous coronary intervention (PCI) using drug‐eluting stents (DES) for coronary bifurcation lesions in patients with or without acute coronary syndrome (ACS). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27877
Abstract: Published data about nonagenarians with acute coronary syndrome (ACS) were mainly descriptive and limited by small sample sizes and unadjusted outcomes. We aim to describe the characteristics, management, and the impact of an invasive strategy… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27895
Abstract: To compare coronary revascularization appropriateness for non‐acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria (AUC). read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28193
Abstract: Patients with acute coronary syndrome (ACS) might represent a specific subgroup, in which bioresorbable scaffold implantation in percutaneous coronary intervention (PCI), might lead to better outcomes when compared to conventional treatment with metallic drug eluting… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28611
Abstract: Fractional flow reserve (FFR) assessment has been validated as an effective tool to guide revascularization of stable coronary artery disease. The role of utilizing FFR in acute coronary syndrome (ACS) is less established. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28653
Abstract: To investigate the optimal dual antiplatelet therapy (DAPT) duration for diabetic patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28959
Abstract: To report our initial experience of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)/acute coronary syndrome (ACS) patients undergoing standard of care invasive management. read more here.